NCT06089746

Brief Summary

Lumbosacral spinal stenosis (LSS) is a leading cause of limited mobility, reduced independence, and poor health outcomes in older adults, and is very common in older adult Veterans. Several years ago, major research studies indicated that surgery for LSS was more effective than usual (medical) management. Nonetheless, there are many patients for whom surgery is not the ideal therapy. There have been reports that modifications in daily activities including temporary use of a modified rolling walker and changes in sleep positioning may help relieve LSS. The investigators have assembled a VA team to study this carefully. The investigators will recruit a small group of older adult Veterans with LSS to try out this program; the investigators will monitor them closely for relief of their symptoms and improvements in walking. The investigators will, as part of this small study, try to understand potential barriers to use of this therapy. The investigators will interview the Veterans and healthcare providers to identify problems that may arise in trying this therapy. If this small study works, the investigators plan to expand the effort.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
7mo left

Started Nov 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress72%
Nov 2024Nov 2026

First Submitted

Initial submission to the registry

August 21, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 18, 2023

Completed
1.1 years until next milestone

Study Start

First participant enrolled

November 15, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2026

Last Updated

December 16, 2025

Status Verified

December 1, 2025

Enrollment Period

1.9 years

First QC Date

August 21, 2023

Last Update Submit

December 8, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in mobility by actigraph (positive, negative, or zero) as determined by the difference in mobility at Week 6 compared to baseline

    Actigraph mobility

    Week 6

Study Arms (1)

Feasibility

EXPERIMENTAL

Patients with LSS will receive DME and training to support continuous maintenance of flexion posture during the 6 week trial. All participants will be asked to wear actigraphs and pedometers intermittently and to complete questionnaires and mobility assessments.

Other: NIPT

Interventions

NIPTOTHER

Coordinated suite of DME and training to support continuous maintenance of flexion posture during the 6 week trial.

Feasibility

Eligibility Criteria

Age60 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Veterans receiving care at participating VA
  • Ability to read and write English and understand instructions
  • Agrees to comply with instructions
  • Symptoms for over 3 months
  • Diagnosis of Lumbar Spinal Stenosis as the cause of symptoms
  • Discomfort involving low back pain and / or neurogenic claudication of legs or thighs
  • Back and/or leg symptoms greater than 3/10 provoked by walking and / or standing
  • X ray, CT, or MRI performed within the last 12 months shows Lumbar Spinal Stenosis at 1 or 2 levels
  • Prior treatment for Spinal Stenosis including therapy, medication, epidural injections, but not surgery
  • Relief of pain (standardly within 5 minutes) by sitting down
  • Ability to walk 50 feet without a cane or walker
  • General health presents ability to increase activity level if Back and / or leg symptoms resolve
  • If home has stairs and patient uses multiple levels, must have steady handrail
  • Transportation routinely available by car or car service and not by bus
  • Home location allows restriction of walking to flat surfaces (lack of hills), with availability to increase ambulation on flat surfaces

You may not qualify if:

  • Previous Low Back Surgery for SS including decompression or fusion
  • Successful Spinal Stenosis Treatment (such as injection) over the prior 3 months
  • X ray, CT, or MRI shows Lumbar Spinal Stenosis in 3 or 4 levels
  • Prior Lumbar Fracture
  • Scoliosis with Cobb angle over 20 degrees on weight bearing AP Views
  • Inflammatory arthropathy involving the Lumbar Spine, such as RA
  • Radiculopathy attributed to herniated disc
  • Suspected or confirmed moderate to severe large fiber neuropathy
  • Failure of relief of back or leg pain brought on by standing or walking, within 5 minutes, by sitting down
  • Rapid increase in symptoms with lumbar flexion such as sitting, Increase in symptoms brought on by leaning on grocery cart or walker
  • Reduced symptoms by lumbo-sacral extension
  • Vascular Claudication with ABI less than 60 or over 140
  • Prior bypass or stent surgery for PAD
  • Current foot, ankle, leg, or thigh infection or open ulcer
  • Current use of a Brace for foot, ankle, or knee pathology,
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

Baltimore, Maryland, 21201, United States

RECRUITING

MeSH Terms

Conditions

Spinal Stenosis

Interventions

dichlorobis(azomycin)platinum II

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal Diseases

Study Officials

  • Beth B. Hogans, MD

    Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Beth B Hogans, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 21, 2023

First Posted

October 18, 2023

Study Start

November 15, 2024

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

November 30, 2026

Last Updated

December 16, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share

A Limited Dataset will be created and shared pursuant to a Data Use Agreement appropriately limiting the use of the dataset and prohibiting the recipient from identifying or re-identifying or taking steps to identify or re-identify any individual whose data are included in the dataset.

Locations